Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01048125 · ClinicalTrials.gov registry record · NA
Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy
A NA study, sponsored by University of Missouri-Columbia.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01048125 is a NA study that was terminated before completion, run by University of Missouri-Columbia. The registered enrollment target is 2 participants.
The verdict
NCT01048125, a NA study, was terminated before completion, sponsored by University of Missouri-Columbia.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Stress (Takotsubo) cardiomyopathy (SC) is a peculiar form of acute, reversible myocardial dysfunction predominantly affecting the apical and mid left ventricular segments. In this institution over the last two to three years the investigators have identified more than a dozen patients with stress cardiomyopathy. The investigators' overarching goal is to characterize these individuals with the hope of identifying risk factors and developing strategies to prevent the occurrence of SC in situations where the likelihood in susceptible individuals may be high.
Interventions
- DEVICE Sympathetic Nerve Activity
- BEHAVIORAL Mental Stress Test (Color Word Test)
- DRUG The Modified Oxford Technique for Baroreflex Sensitivity
- OTHER Cold Pressor Test
- DEVICE Echocardiographic evaluation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-08 |
| Est. Completion | 2012-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01048125
The ClinicalTrials.gov registry entry for NCT01048125 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Sympathetic Nerve Activity is the first listed.
NCT01048125 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01048125 about?
NCT01048125 is a clinical study titled "Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy". Stress (Takotsubo) cardiomyopathy (SC) is a peculiar form of acute, reversible myocardial dysfunction predominantly affecting the apical and mid left ventricular segments. In this institution over the last two to three years the investigators have identified more than a dozen patients with stress c...
What is the current status of trial NCT01048125?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2009-08. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01048125?
The interventions under investigation include: Sympathetic Nerve Activity (DEVICE), Mental Stress Test (Color Word Test) (BEHAVIORAL), The Modified Oxford Technique for Baroreflex Sensitivity (DRUG), Cold Pressor Test (OTHER), Echocardiographic evaluation (DEVICE).
Who is sponsoring clinical trial NCT01048125?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.